Trials / Unknown
UnknownNCT05912699
A Study to Evaluate the Effect of SlimBiotics L. Fermentum K8 Postbiotic on Weight Management and Metabolic Health Outcomes
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of SlimBiotics L. Fermentum K8 Postbiotic on Weight Management and Metabolic Health Outcomes
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Slimbiotics · Unknown
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study is to evaluate the efficacy of a postbiotic supplement on weight management and metabolic health. This study will be conducted as a hybrid trial consisting of both in-person visits and virtual assessments. Two groups will be included: the intervention (SlimBiotics postbiotic) and placebo. The SlimBiotics postbiotic formula is the first plant-based postbiotic targeting weight management and metabolic health. Other competing postbiotics are isolated from humans (feces) but the strains in SlimBiotics were isolated from a fermented plant (millet porridge cereal) This product contains L. fermentum K8 Postbiotic.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Slimbiotics Postbiotic | SlimBiotics postbiotic formula contains the following ingredients: * Heat-inactivated L. fermentum K8 Postbiotic. * Microcrystalline cellulose. |
| OTHER | Placebo | The placebo capsules contain microcrystalline cellulose only. |
Timeline
- Start date
- 2023-07-01
- Primary completion
- 2023-09-23
- Completion
- 2023-09-30
- First posted
- 2023-06-22
- Last updated
- 2023-06-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05912699. Inclusion in this directory is not an endorsement.